Results 171 to 180 of about 18,742 (250)

Effect of sodium–glucose cotransporter 2 inhibitors on heart failure readmission in older patients with diabetes: A Japanese claims‐based cohort study

Journal of Diabetes Investigation, Volume 17, Issue 7, Page 1132-1141, July 2026.
SGLT2 inhibitor use at discharge was associated with a reduced risk of heart failure readmission in elderly patients with diabetes, with no significant differences among individual agents. ABSTRACT Aims To evaluate the effect of sodium–glucose cotransporter 2 inhibitor (SGLT2i) administration at hospital discharge on heart failure (HF) readmission ...
Kazuya Hiura, Hirotaka Masuda, Masayuki Sakunami, Miki Yamashita   +3 more
wiley   +1 more source

Prevalence of Therapeutic Inertia in the Management of Overweight and Obesity in Patients With a Diagnosis of Type 2 Diabetes Who Are Followed up by Primary Care Physicians. [PDF]

Obes Sci Pract
Aschner P, Henao-Carrillo D.
europepmc   +1 more source

Cardiac remodelling in type 2 diabetes: Pathophysiological mechanisms and opportunities for multiscale computational modelling and simulation

The Journal of Physiology, Volume 604, Issue 13, Page 5170-5199, 1 July 2026.
Abstract figure legend Overview of multiscale cardiac remodelling in type 2 diabetes and how to model and simulate these changes using a human‐based, multiscale computational framework. Cardiac remodelling in type 2 diabetes occurs at ionic channel, protein, cellular, tissue and whole‐organ level, affecting the electrophysiological function, mechanical
Ambre Bertrand, Jakub Tomek, Blanca Rodriguez   +2 more
wiley   +1 more source

Two cases (a decade apart) of severe sulfonylurea-positive hypoglycemia associated with inhaled heroin use. [PDF]

JCEM Case Rep
Weisbrot B, Kim KY, Zacharia C, Hwang JL.   +3 more
europepmc   +1 more source

Correlation of Candida Species and Carriage in Uncontrolled and Controlled Diabetics on Various Oral Hypoglycemic Drug Regimen.

J Pharm Bioallied Sci
Upadhyay AK, Nathani D, Pandey R, Umbarkar AA, Sao K, Bhansali D, Shrivastava S.   +6 more
europepmc   +1 more source

Determinants and predictive performance of reduced muscle mass in elderly patients with type 2 diabetes: a retrospective study. [PDF]

Front Endocrinol (Lausanne)
Wang K, Fu W, Pan H, Dong J.
europepmc   +1 more source

Patients' Attitudes Towards Deprescribing Differ Across Specific Cardiovascular and Diabetes Medication: A Survey Study Assessing Within-Patient Differences. [PDF]

Basic Clin Pharmacol Toxicol
Stuijt PJC, Crutzen S, Heringa M, Hootsen JV, van Munster BC, Wildeboer AT, Taxis K, Denig P.   +7 more
europepmc   +1 more source

Population attributable fraction of associated factors to adherence to blood glucose self-monitoring in diabetic type 2 patients treated with insulin or sulfonylureas/meglitinides: The results of DiaCare study in Iran. [PDF]

J Educ Health Promot
Mohammadi A, Shafiee G, Olyaeemanesh A, Daroudi R, Aghakhani A, Nasli-Esfahani E, Razi F, Heshmat R, Takian A.   +8 more
europepmc   +1 more source

Comparative cardiovascular risk of sulfonylureas with low- and high-affinities for cardiac mitochondrial adenosine triphosphate-sensitive potassium channels versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: A cohort study. [PDF]

Diabetes Obes Metab
Chen MH, Lin LY, Hung TY, Lin TC, Li CY, Lin TH, Chen YH, Liou JT, Wang MT.   +8 more
europepmc   +1 more source

The therapeutic value of antidiabetic drugs in lung cancer treatment: from clinical evidence to possible mechanisms. [PDF]

Front Immunol
Wang Q, Xu J, Liu Q, Zhou H, Hu Y.
europepmc   +1 more source